Kingfisher Airlines is battling on many fronts - huge debt, cancellations, and mounting weariness from the government and public.

The shares of Sun Pharmaceutical Industries fall after US-based Wyeth Pharmaceuticals seeks damages worth $960 million in a patent dispute.

We bring you six index heavyweight stocks that are capable of delivering steady returns in the long run.

Amid news that the company is likely to enter into a marketing tie up with US drug major Merck & Co, Sun Pharma's shares jumped to touch Rs 455.90 on BSE.

Although our fund manager has taken tentative investment steps, he is convinced there will be aggressive churning — stock changes as well as trading in and out of the same stocks.

Both professionally managed family businesses and MNC subsidiaries make for good stock picks, not only because they weather the downturns better but also because they offer long-term investors a chance to create wealth.

After almost a three-month hiatus, Dipen Sheth decides to venture into the stock markets and buys 10 stocks for reconstructing the Safe Wealth portfolio.

Don't shy away from equities because of the slowdown. Here are four investment ideas that could yield rich rewards if you stay put for the long term.

The year 2007 was remarkable for virtually every asset class. Money Today reached out to experts on stocks, real estate, mutual funds and commodities for their views on the way the markets will pan out in the coming times.

With the markets at a 24-month low, this may be the last fortnight when Dipen Sheth resists the temptation to buy.

As the inflation rate moves up, key market indices are spiralling downward. Is there a way of making sure that your portfolio is not affected by this rising rate?

Reacting to the recent volatility in the mid-cap sector, and wary of more in the global financial markets, we book profits in a number of shares.

MONEY TODAY portfolios have seen some rejigs. However, more than short-term volatility, it has to do with our long-term objectives.

Here we explain the rationale for choosing each stock in Safe Wealth, the 'safer' of our two portfolios.

This selection of research reports gives information and opinions on companies and industries.They are often filled with jargon, which we must reluctantly inflict on readers sincethe excerpts are verbatim. Seven such terms occur in these extracts: EBITDA = EarningsBefore Interest,Tax, Depreciation,Amortisation, EV = Enterprise Value, EPS = Earnings Per Share, PE = Price-Earnings, PAT/PBT = Profit After/ Before Tax,YoY = Year-on-year.

A healthy dose of pharma stocks in your portfolio can be a good defensive strategy in this volatile market.

Investors have been lukewarm to the FMCG and pharma sectors. But the future looks brighter than the immediate past.

Real estate, financial services and infrastructure firms made hay as the sun shone on Dalal Street. But these may tumble the hardest as markets return closer to fundamentals.